Indications for Dilation and Curettage Based on Ultrasound Findings

Primary Indications for D&C

Endometrial thickness >3-4mm on transvaginal ultrasound should prompt endometrial sampling, with D&C serving as the definitive diagnostic step when initial office biopsy is inadequate, as recommended by the American College of Obstetricians and Gynecologists 1
The diagnostic pathway should begin with transvaginal ultrasound measurement of endometrial thickness, followed by endometrial sampling, with hysteroscopy as the final step, according to the American College of Radiology 1
Office endometrial biopsy has a 10% false-negative rate, requiring fractional D&C under anesthesia when symptoms persist despite negative office biopsy, as stated by the American College of Obstetricians and Gynecologists 2
Pipelle or Vabra devices are highly sensitive (99.6% and 97.1% respectively) for detecting endometrial carcinoma, but D&C remains superior for accurate tumor grading, as recommended by the Society of Gynecologic Oncology 1

D&C is the optimal method to obtain histologic characteristics when considering conservative management of grade 1 endometrial cancer or atypical hyperplasia in young women desiring fertility, as stated by the American Society for Reproductive Medicine 3
D&C is superior to pipelle biopsy for accuracy of tumor grade assessment in this specific population, according to the Society of Gynecologic Oncology 3

Prior uterine surgery (cesarean delivery, myomectomy, prior D&C) increases risk of placenta accreta spectrum disorder, making ultrasound evaluation critical before any subsequent D&C procedure, as recommended by the American College of Radiology 4
Women with placenta previa and three prior cesarean deliveries have up to 40% risk of placenta accreta spectrum disorder, as stated by the American College of Obstetricians and Gynecologists 4

Endoscopists performing fewer than 500 diagnostic procedures are four times more likely to cause uterine perforation, as stated by the American College of Obstetricians and Gynecologists 2
Post-procedure monitoring should include watching for excessive bleeding, fever, or severe unrelieved abdominal pain, as recommended by the American College of Obstetricians and Gynecologists 5, 2

Office endometrial biopsy has a 10% false-negative rate, making fractional D&C under anesthesia mandatory when initial office sampling is negative but menorrhagia persists, as recommended by the National Comprehensive Cancer Network 6
D&C is superior to office biopsy methods for accurate tumor grading, which is critical for treatment planning, especially when fertility-sparing treatment is being considered for grade 1 endometrial cancer or atypical hyperplasia in reproductive-age women, according to the European Society for Medical Oncology 7

Hysteroscopy may reveal focal lesions such as polyps in patients with persistent undiagnosed menorrhagia, and D&C provides definitive tissue diagnosis of these lesions, as suggested by the National Comprehensive Cancer Network 6

Initial assessment using transvaginal ultrasound to measure endometrial thickness and identify structural abnormalities is recommended, followed by office endometrial biopsy if endometrial thickness ≥3-4mm or structural lesions are present, and fractional D&C under anesthesia if office biopsy is negative but symptoms persist, as outlined by the National Comprehensive Cancer Network 6
If fertility-sparing treatment is considered, hysteroscopy with D&C is recommended for direct visualization and accurate grading, as suggested by the European Society for Medical Oncology and the National Comprehensive Cancer Network 6, 7